Researcher profile

Ronghui Xu

Ronghui Xu contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

Causal Effects of Prenatal Drug Exposure on Birth Defects with Missing by Terathanasia

A recent cohort study revealed a positive correlate between major structural birth defects in infants and a certain medication taken by pregnant women. To draw valid causal inference, an outstanding problem to overcome was the missing birth defect outcomes among pregnancy losses resulting from spontaneous abortion. This led to missing not at random since, according to the theory of "terathanasia", a defected fetus is more likely to be spontaneously aborted. Other complications in the data included left truncation, right censoring, observational nature, and rare events. In addition, the previous analysis stratified on live birth against spontaneous abortion, which was itself a post-exposure variable and hence did not lead to a causal interpretation of the stratified results. In this paper we aim to estimate and provide inference for the causal parameters of scientific interest, including the principal effects, making use of the missing data mechanism informed by "terathanasia". The rare events with missing outcomes led to multiple sensitivity analyses where the causal parameters can be estimated with better confidence in each setting. Our findings should shed light on how studies on causal effects of medication or other exposures during pregnancy may be analyzed using state-of-the-art methodologies.

preprint2022arXiv

Doubly Robust Inference for Hazard Ratio under Informative Censoring with Machine Learning

Randomized clinical trials with time-to-event outcomes have traditionally used the log-rank test followed by the Cox proportional hazards (PH) model to estimate the hazard ratio between the treatment groups. These are valid under the assumption that the right-censoring mechanism is non-informative, i.e. independent of the time-to-event of interest within each treatment group. More generally, the censoring time might depend on additional covariates, and inverse probability of censoring weighting (IPCW) can be used to correct for the bias resulting from the informative censoring. IPCW requires a correctly specified censoring time model conditional on the treatment and the covariates. Doubly robust inference in this setting has not been plausible previously due to the non-collapsibility of the Cox model. However, with the recent development of data-adaptive machine learning methods we derive an augmented IPCW (AIPCW) estimator that has the following doubly robust (DR) properties: it is model doubly robust, in that it is consistent and asymptotic normal (CAN), as long as one of the two models, one for the failure time and one for the censoring time, is correctly specified; it is also rate doubly robust, in that it is CAN as long as the product of the estimation error rates under these two models is faster than root-$n$. We investigate the AIPCW estimator using extensive simulation in finite samples.

preprint2020arXiv

Explained Variation under the Additive Hazards Model

We study explained variation under the additive hazards regression model for right-censored data. We consider different approaches for developing such a measure, and focus on one that estimates the proportion of variation in the failure time explained by the covariates. We study the properties of the measure both analytically, and through extensive simulations. We apply the measure to a well-known survival data set as well as the linked Surveillance, Epidemiology and End Results (SEER)-Medicare database for prediction of mortality in early-stage prostate cancer patients using high dimensional claims codes.